GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Cyclically Adjusted PB Ratio

DaVita (BSP:DVAI34) Cyclically Adjusted PB Ratio : 6.62 (As of May. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is DaVita Cyclically Adjusted PB Ratio?

As of today (2024-05-26), DaVita's current share price is R$711.74. DaVita's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was R$107.55. DaVita's Cyclically Adjusted PB Ratio for today is 6.62.

The historical rank and industry rank for DaVita's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSP:DVAI34' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.13   Med: 4.35   Max: 7.76
Current: 6.17

During the past years, DaVita's highest Cyclically Adjusted PB Ratio was 7.76. The lowest was 2.13. And the median was 4.35.

BSP:DVAI34's Cyclically Adjusted PB Ratio is ranked worse than
82.02% of 317 companies
in the Healthcare Providers & Services industry
Industry Median: 1.99 vs BSP:DVAI34: 6.17

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

DaVita's adjusted book value per share data for the three months ended in Mar. 2024 was R$52.578. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$107.55 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


DaVita Cyclically Adjusted PB Ratio Historical Data

The historical data trend for DaVita's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Cyclically Adjusted PB Ratio Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.54 5.46 5.00 3.22 4.66

DaVita Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.50 4.35 4.12 4.66 6.15

Competitive Comparison of DaVita's Cyclically Adjusted PB Ratio

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Cyclically Adjusted PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PB Ratio falls into.



DaVita Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

DaVita's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=711.74/107.55
=6.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, DaVita's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=52.578/131.7762*131.7762
=52.578

Current CPI (Mar. 2024) = 131.7762.

DaVita Quarterly Data

Book Value per Share CPI Adj_Book
201406 49.828 100.560 65.296
201409 54.129 100.428 71.025
201412 63.346 99.070 84.259
201503 72.618 99.621 96.057
201506 74.329 100.684 97.283
201509 92.310 100.392 121.168
201512 90.118 99.792 119.001
201603 84.282 100.470 110.544
201606 78.527 101.688 101.762
201609 79.585 101.861 102.958
201612 80.130 101.863 103.661
201703 82.608 102.862 105.829
201706 87.630 103.349 111.733
201709 79.203 104.136 100.226
201712 84.695 104.011 107.304
201803 84.163 105.290 105.335
201806 94.467 106.317 117.089
201809 94.674 106.507 117.136
201812 86.437 105.998 107.458
201903 89.450 107.251 109.905
201906 94.927 108.070 115.751
201909 71.338 108.329 86.778
201912 69.583 108.420 84.573
202003 78.138 108.902 94.551
202006 91.613 108.767 110.993
202009 74.737 109.815 89.683
202012 64.749 109.897 77.640
202103 63.923 111.754 75.375
202106 60.831 114.631 69.929
202109 58.834 115.734 66.989
202112 43.914 117.630 49.195
202203 44.089 121.301 47.896
202206 33.108 125.017 34.898
202209 30.999 125.227 32.620
202212 41.327 125.222 43.490
202303 47.430 127.348 49.079
202306 54.107 128.729 55.388
202309 64.834 129.860 65.791
202312 58.257 129.419 59.318
202403 52.578 131.776 52.578

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DaVita  (BSP:DVAI34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


DaVita Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of DaVita's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (BSP:DVAI34) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (BSP:DVAI34) Headlines

No Headlines